文献速递乳房整形与再造显微修复重建

静脉流出道增强可降低DIEP皮瓣乳房再造脂肪坏死风险:一项回顾性分析

Venous outflow augmentation protects against fat necrosis in the DIEP flap breast reconstruction: A retrospective analysis.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2025-08-20

该回顾性研究纳入2012至2023年伦敦某三级中心119例单侧单蒂DIEP皮瓣乳房再造患者,58.8%接受SIEV静脉增强。SIEV增强组脂肪坏死率显著低于对照组(10.0% vs 26.5%,P=0.025),多因素分析显示SIEV增强是脂肪坏死的独立保护因素(调整OR 0.33,95%CI 0.12-0.95,P=0.039)。

要点

  • SIEV静脉增强与DIEP皮瓣术后脂肪坏死率降低显著相关(10.0% vs 26.5%)。
  • 多因素分析证实SIEV增强是脂肪坏死的独立保护因素(调整OR 0.33)。
  • 在符合条件的病例中,可考虑将SIEV静脉增强纳入常规手术实践。

核心结论

  • 在DIEP皮瓣乳房再造队列中,SIEV静脉增强是脂肪坏死的显著独立保护因素。

研究设计与样本

  • 回顾性分析2012至2023年英国伦敦某三级中心单侧单蒂DIEP皮瓣乳房再造患者119例(119个皮瓣),按SIEV静脉增强状态分组。

主要发现

  • 总队列脂肪坏死发生率为16.8%,SIEV增强组为10.0%,对照组为26.5%(P=0.025)。
  • 多因素分析显示SIEV增强对脂肪坏死的调整OR为0.33(95%CI 0.12-0.95,P=0.039)。

关键数值与推荐

  • SIEV增强组脂肪坏死率10.0% vs 对照组26.5%(P=0.025)。
  • 调整OR 0.33(95%CI 0.12-0.95,P=0.039)支持SIEV增强的保护作用。

临床怎么用

  • 在符合条件的DIEP皮瓣乳房再造病例中,可考虑将SIEV静脉增强作为常规手术实践的一部分。

局限性

  • 本研究为回顾性分析,需前瞻性研究验证SIEV增强与脂肪坏死的关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the deep inferior epigastric perforator (DIEP) flap breast reconstruction, fat necrosis is a common and distressing complication for patients. While venous outflow augmentation using the superficial inferior epigastric vein (SIEV) has been suggested to improve some perfusion-related outcomes, its effect on fat necrosis remains insufficiently substantiated. METHODS: A retrospective review was conducted of unilateral, unipedicled DIEP flap breast reconstructions performed between 2012 and 2023 at a tertiary centre in London, United Kingdom. Patients were categorised based on SIEV venous augmentation status, and the incidence of postoperative clinical fat necrosis was recorded. Univariable and multivariable logistic regression models assessed the relationship between fat necrosis and SIEV augmentation, as well as patient, surgical and perfusion-related factors. RESULTS: The total cohort included 119 patients (119 flaps). Of the total flaps, 58.8% received venous augmentation with the SIEV. Fat necrosis occurred in 16.8% of the total cases. Patients in the SIEV-augmented group experienced significantly lower fat necrosis rates compared to controls (10.0% vs. 26.5%, respectively; P = 0.025). Multivariable analysis further demonstrated a protective effect from SIEV augmentation against fat necrosis (adjusted odds ratio 0.33, 95% confidence interval 0.12-0.95; P = 0.039). CONCLUSIONS: In the present cohort of DIEP flap breast reconstructions, venous augmentation using SIEV was a significant independent protective factor against fat necrosis. While prospective studies are necessary to validate this relationship, this technique may be considered as part of routine surgical practice in eligible cases.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Shtarbanov P, Tannirandorn P, Luo N, et al. Venous outflow augmentation protects against fat necrosis in the DIEP flap breast reconstruction: A retrospective analysis. J Plast Reconstr Aesthet Surg. 2025. PMID: 40885116. doi:10.1016/j.bjps.2025.08.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。